Bleeding is the most common complication of warfarin treatment; patients > 65 years and those with comorbidities (especially diabetes, recent myocardial infarction, hematocrit < 30%, or creatinine > 1.5 mg / dL [> 133 micromol / L]) and a history of stroke or gastrointestinal bleeding seem to be at greatest risk.